Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL627761 | 0.79 | SLC6A2 (0.39) | SLC6A2SSTR4 | |
| SCHEMBL19366757 | 0.79 | SLC6A2 (0.39) | SLC6A2SSTR4 | |
| SCHEMBL12504907 | 0.79 | SLC6A2 (0.39) | SLC6A2SSTR4 | |
| SCHEMBL17409968 | 0.79 | SLC6A2 (0.39) | SLC6A2SSTR4 | |
| Hydrochloric Acid SCHEMBL22612729 | 0.77 | SLC6A2 (0.38) | SLC6A2SSTR4 | |
| SCHEMBL1287870 | 0.75 | SLC6A2 (0.37) | SLC6A2SSTR4 | |
| SCHEMBL1992859 | 0.75 | SLC6A2 (0.37) | SLC6A2SSTR4 | |
| SCHEMBL23089746 | 0.75 | SLC6A2 (0.44) | SLC6A2SSTR4 | |
| SCHEMBL22487983 | 0.75 | SLC6A2 (0.37) | SLC6A2SSTR4 | |
| SCHEMBL4201451 | 0.75 | SLC6A2 (0.37) | SLC6A2SSTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127297-A1 | Novel Antibacterial 3\"-Derivatives Of 4,6-Disubstituted 2,5-Dideoxystreptamine Aminoglycoside Antibiotics | AGILEBIOTICS B.V. (NL) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127297-A1 | Novel Antibacterial 3\"-Derivatives Of 4,6-Disubstituted 2,5-Dideoxystreptamine Aminoglycoside Antibiotics | ABCC1, AMPD3, MRPS35 | SLC6A2 1311/4885SSTR4 4004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.